Skip to content

NEO

NeoGenomics, Inc.

Stock

$18.47+0.69 (+3.88%)Close Oct 2, 2026

Income statement

LineLast 12 months20252024202320222021202020192018201720162015201420132012
Revenue$766M$727M$661M$592M$510M$484M$444M$409M$277M$240M$232M$105M$92M$71M$65M
Cost of revenue$430M$413M$370M$347M$322M$297M$259M$212M$149M$138M$134M$61M$51M$40M$38M
Gross profit$337M$314M$290M$245M$188M$187M$186M$197M$127M$102M$98M$44M$41M$32M$27M
R&D$38M$37M$31M$27M$30M$22M$8.2M$8.5M$3.0M$3.6M$4.6M$4.2M$2.7M$2.4M$2.3M
SG&A$359M$365M$344M$314M$311M$284M$192M$175M$114M$94M$88M$45M$36M$26M$23M
Other operating expenses$7.7M$28M$6.7M$11M$4.5M————$1.1M$3.5M————
Operating income−$68M−$116M−$92M−$108M−$158M−$119M−$14M$13M$10M$2.9M$2.2M−$5.6M$2.2M$3.2M$1.2M
Non-operating income$14M$5.6M$11M$11M−$1.7M$104M−$64K−$9.4M−$6.2M−$5.6M−$10.0M$1.1M−$929K−$989K−$1.1M
Pretax income−$55M−$110M−$81M−$97M−$159M−$15M−$14M$3.6M$3.8M−$2.7M−$7.8M−$4.5M$1.3M$2.2M$65K
Taxes−$2.7M−$2.2M−$1.9M−$9.1M−$15M−$6.7M−$18M−$4.4M$1.2M−$2.3M−$1.7M−$2.0M$157K$152K$0
Net income−$52M−$108M−$79M−$88M−$144M−$8.3M$4.2M$8.0M$2.6M−$396K−$6.1M−$2.5M$1.1M$2.0M$65K
Diluted EPS———————————−$0.04$0.02$0.04$0.00
Diluted shares—128.1M126.7M125.5M124.2M120.0M111.8M103.6M91.6M79.4M77.5M60.5M56.0M52.8M48.7M
Revenue growth—+10.1%+11.6%+16.1%+5.2%+9.0%+8.7%+47.7%+15.2%+3.6%+121.2%+13.8%+28.8%+10.2%—
Gross margin43.9%43.2%43.9%41.3%36.9%38.6%41.8%48.1%46.0%42.4%42.3%41.8%44.2%44.4%41.4%
Operating margin−8.9%−15.9%−13.9%−18.2%−30.9%−24.5%−3.1%3.2%3.6%1.2%0.9%−5.4%2.4%4.4%1.9%
Net margin−6.8%−14.9%−11.9%−14.9%−28.3%−1.7%0.9%2.0%1.0%−0.2%−2.6%−2.4%1.2%2.8%0.1%

Revenue to net income